Chemring(DE:CMN1)
€6.56+0.04 (+4.05%)
DE:CMN1
Chemring financials statements
€6.56
At close:+0.04 (+4.05%)
Chemring (CMN1) Ratios
1 Followers
Chemring Ratios
DE:CMN1's free cash flow for Q2 2026 was £-31.00M. For the 2026 fiscal year, DE:CMN1's free cash flow was decreased by £-39.90M and operating cash flow was £8.90M. See a summary of the company’s cash flow.
| Ratios | Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.60 | 1.22 | 1.29 | 1.59 | 1.44 |
| Quick Ratio | 0.89 | 0.64 | 0.58 | 0.72 | 0.66 |
| Cash Ratio | 0.32 | 0.20 | 0.05 | 0.17 | 0.06 |
| Solvency Ratio | 0.16 | 0.19 | 0.13 | 0.34 | 0.37 |
| Operating Cash Flow Ratio | 0.42 | 0.37 | 0.46 | 0.71 | 0.74 |
| Short-Term Operating Cash Flow Coverage | 1.79 | 1.88 | 59.91 | 44.72 | 189.25 |
| Net Current Asset Value | £ -159.60M | £ -66.00M | £ -34.20M | £ -20.80M | £ -30.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.14 | 0.03 | 0.04 | 0.06 |
| Debt-to-Equity Ratio | 0.40 | 0.27 | 0.05 | 0.06 | 0.09 |
| Debt-to-Capital Ratio | 0.29 | 0.22 | 0.05 | 0.06 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.11 | 0.04 | 0.05 | 0.07 |
| Financial Leverage Ratio | 2.26 | 1.94 | 1.58 | 1.48 | 1.51 |
| Debt Service Coverage Ratio | 1.62 | 1.51 | 33.72 | 20.52 | 34.10 |
| Interest Coverage Ratio | 12.88 | 12.10 | 64.86 | 32.93 | 31.50 |
| Debt to Market Cap | 0.09 | 0.09 | 0.02 | 0.03 | 0.03 |
| Interest Debt Per Share | 0.59 | 0.38 | 0.08 | 0.10 | 0.12 |
| Net Debt to EBITDA | 0.89 | 0.64 | 0.21 | 0.10 | 0.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | 14.75% | 11.38% | 9.48% | 12.32% | 12.81% |
| EBITDA Margin | 20.14% | 16.20% | 14.20% | 17.76% | 19.20% |
| Operating Profit Margin | 14.75% | 11.38% | 9.61% | 12.32% | 12.81% |
| Pretax Profit Margin | 13.61% | 10.44% | 9.33% | 11.95% | 12.41% |
| Net Profit Margin | 9.69% | 7.74% | 1.14% | 11.82% | 10.55% |
| Continuous Operations Profit Margin | 10.71% | 8.37% | 7.98% | 11.07% | 10.55% |
| Net Income Per EBT | 71.20% | 74.11% | 12.24% | 98.96% | 85.04% |
| EBT Per EBIT | 92.23% | 91.74% | 97.14% | 96.96% | 96.83% |
| Return on Assets (ROA) | 5.58% | 5.71% | 0.91% | 7.64% | 7.81% |
| Return on Equity (ROE) | 12.62% | 11.09% | 1.43% | 11.34% | 11.76% |
| Return on Capital Employed (ROCE) | 11.09% | 12.36% | 9.99% | 9.76% | 11.75% |
| Return on Invested Capital (ROIC) | 8.12% | 9.03% | 8.50% | 8.98% | 9.95% |
| Return on Tangible Assets | 6.89% | 6.99% | 1.15% | 10.39% | 10.96% |
| Earnings Yield | 3.11% | 4.08% | 0.69% | 5.60% | 5.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.97 | 6.18 | 11.44 | 12.04 | 7.20 |
| Payables Turnover | 0.00 | 5.97 | 9.03 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 1.31 | 1.45 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.40 | 1.77 | 1.95 | 1.73 | 1.98 |
| Asset Turnover | 0.58 | 0.74 | 0.79 | 0.65 | 0.74 |
| Working Capital Turnover Ratio | 5.92 | 11.41 | 8.66 | 7.09 | 7.64 |
| Cash Conversion Cycle | 73.51 | 276.40 | 243.66 | 30.31 | 50.67 |
| Days of Sales Outstanding | 73.51 | 59.07 | 31.90 | 30.31 | 50.67 |
| Days of Inventory Outstanding | 0.00 | 278.46 | 252.18 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 61.13 | 40.42 | 0.00 | 0.00 |
| Operating Cycle | 73.51 | 337.53 | 284.07 | 30.31 | 50.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.31 | 0.30 | 0.23 | 0.29 | 0.27 |
| Free Cash Flow Per Share | -0.02 | 0.04 | 0.11 | 0.16 | 0.16 |
| Dividend Paid and CapEx Coverage Ratio | 0.76 | 0.91 | 1.28 | 1.65 | 1.80 |
| Capital Expenditure Coverage Ratio | 0.94 | 1.16 | 1.93 | 2.33 | 2.51 |
| Operating Cash Flow Coverage Ratio | 0.55 | 0.83 | 3.18 | 2.99 | 2.34 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.16 | 0.14 | 0.20 | 0.19 |
| Free Cash Flow Yield | -0.36% | 1.18% | 4.03% | 5.43% | 5.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.83 | 24.52 | 145.78 | 17.87 | 19.64 |
| Price-to-Sales (P/S) Ratio | 3.12 | 1.90 | 1.67 | 2.11 | 2.07 |
| Price-to-Book (P/B) Ratio | 4.06 | 2.72 | 2.08 | 2.03 | 2.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -277.01 | 84.97 | 24.83 | 18.42 | 17.91 |
| Price-to-Operating Cash Flow Ratio | 18.34 | 11.96 | 11.95 | 10.52 | 10.77 |
| Price-to-Earnings Growth (PEG) Ratio | 1.11 | 0.04 | -1.64 | 1.34 | 0.79 |
| Enterprise Value Multiple | 16.37 | 12.35 | 11.95 | 12.00 | 11.15 |
| Enterprise Value | 1.64B | 1.02B | 801.53M | 854.23M | 841.60M |
| EV to EBITDA | 16.37 | 12.35 | 11.95 | 12.00 | 11.15 |
| EV to Sales | 3.30 | 2.00 | 1.70 | 2.13 | 2.14 |
| EV to Free Cash Flow | -292.90 | 89.60 | 25.28 | 18.57 | 18.50 |
| EV to Operating Cash Flow | 19.39 | 12.61 | 12.16 | 10.61 | 11.12 |
| Tangible Book Value Per Share | 0.81 | 0.84 | 0.89 | 0.91 | 0.71 |
| Shareholders’ Equity Per Share | 1.41 | 1.31 | 1.34 | 1.49 | 1.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.20 | 0.15 | 0.07 | 0.15 |
| Revenue Per Share | 1.84 | 1.87 | 1.68 | 1.43 | 1.40 |
| Net Income Per Share | 0.18 | 0.14 | 0.02 | 0.17 | 0.15 |
| Tax Burden | 0.71 | 0.74 | 0.12 | 0.99 | 0.85 |
| Interest Burden | 0.92 | 0.92 | 0.98 | 0.97 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.28 | 0.20 | 0.16 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Income Quality | 1.15 | 1.39 | 1.45 | 1.51 | 1.50 |
Currency in GBP
